281 related articles for article (PubMed ID: 12789267)
1. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
Barnes H; Ackermann EJ; van der Geer P
Oncogene; 2003 Jun; 22(23):3589-97. PubMed ID: 12789267
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine-phosphorylated low density lipoprotein receptor-related protein 1 (Lrp1) associates with the adaptor protein SHC in SRC-transformed cells.
Barnes H; Larsen B; Tyers M; van Der Geer P
J Biol Chem; 2001 Jun; 276(22):19119-25. PubMed ID: 11259429
[TBL] [Abstract][Full Text] [Related]
3. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
van der Geer P; Wiley S; Gish GD; Pawson T
Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
5. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
6. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
7. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes.
Ramos-Morales F; Druker BJ; Fischer S
Oncogene; 1994 Jul; 9(7):1917-23. PubMed ID: 8208538
[TBL] [Abstract][Full Text] [Related]
8. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
9. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
van der Geer P; Wiley S; Pawson T
Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of hTAFII68 (NTD)-mediated transactivation by v-Src.
Lee HJ; Kim S; Pelletier J; Kim J
FEBS Lett; 2004 Apr; 564(1-2):188-98. PubMed ID: 15094065
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine residues 239 and 240 of Shc are phosphatidylinositol 4,5-bisphosphate-dependent phosphorylation sites by c-Src.
Sato K; Gotoh N; Otsuki T; Kakumoto M; Aoto M; Tokmakov AA; Shibuya M; Fukami Y
Biochem Biophys Res Commun; 1997 Nov; 240(2):399-404. PubMed ID: 9388490
[TBL] [Abstract][Full Text] [Related]
12. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.
Calderwood DA; Fujioka Y; de Pereda JM; García-Alvarez B; Nakamoto T; Margolis B; McGlade CJ; Liddington RC; Ginsberg MH
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2272-7. PubMed ID: 12606711
[TBL] [Abstract][Full Text] [Related]
13. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
14. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
Liu SK; McGlade CJ
Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
[TBL] [Abstract][Full Text] [Related]
15. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain.
Rojas M; Yao S; Donahue JP; Lin YZ
Biochem Biophys Res Commun; 1997 May; 234(3):675-80. PubMed ID: 9175774
[TBL] [Abstract][Full Text] [Related]
16. Role of tyrosine residues and protein interaction domains of SHC adaptor in VEGF receptor 3 signaling.
Fournier E; Blaikie P; Rosnet O; Margolis B; Birnbaum D; Borg JP
Oncogene; 1999 Jan; 18(2):507-14. PubMed ID: 9927207
[TBL] [Abstract][Full Text] [Related]
17. Identification of a NPXY motif in growth factor receptor-bound protein 14 (Grb14) and its interaction with the phosphotyrosine-binding (PTB) domain of IRS-1.
Rajala RV; Chan MD
Biochemistry; 2005 Jun; 44(22):7929-35. PubMed ID: 15924411
[TBL] [Abstract][Full Text] [Related]
18. Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW
Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.
Ellis C; Moran M; McCormick F; Pawson T
Nature; 1990 Jan; 343(6256):377-81. PubMed ID: 1689011
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc.
Tarr PE; Roncarati R; Pelicci G; Pelicci PG; D'Adamio L
J Biol Chem; 2002 May; 277(19):16798-804. PubMed ID: 11877420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
